ハルシノゲン活性化Gq結合5-HT2Aセロトニン受容体の構造
Kuglae Kim1, Tao Che1, Ouliana Panova2
1Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599-7365, USA.
Cell
|September 18, 2020
まとめ
LSDやサイロシビンのような幻覚剤がセロトニン5HT2A受容体 (HTR2A) を活性化させる仕組みの構造的な洞察が明らかになった. これらの分子メカニズムを理解することは 神経精神疾患の新たな治療法の開発の鍵です
科学分野:
- 神経科学
- 薬理学について
- 構造生物学
背景:
- サイケデリック剤は,ライセルギン酸ジエチラミド (LSD) とサイロシビンを含むもので,そのレクリエーション用途と神経精神疾患における新たな治療の可能性が知られている.
- 5-HT2Aセロトニン受容体 (HTR2A) は,サイケデリックの治療効果と幻覚効果の両方の重要な標的です.
- HTR2Aのサイケデリック作用の基礎となる正確な分子機構は,まだ完全に理解されていません.
研究 の 目的:
- HTR2Aにおける サイケデリック薬の作用の 分子基盤を解明するためです
- ハルシノゲンとGタンパク質の複合体で HTR2Aの活性状態構造を決定する
- 活性化とシグナル伝達を理解するために,異なるリガンドに結合したHTR2Aの構造を比較する.
主な方法:
- 25 - CN- NBOHとGαqヘテロトリマーに結合するHTR2Aの構造を決定するために,冷凍電子顕微鏡 (cryo- EM) を使用した.
- X線結晶学を用いて,LSD (アステリンバイアス型リガンド) とメチオテピン (逆アゴニスト) と複合したHTR2Aの構造を得ました.
主要な成果:
- Gαqとの複合体における幻覚剤25- CN- NBOHと結合したHTR2Aの活性状態構造を決定した.
- 構造的な比較により,HTR2Aの活性化に関わる重要な相互作用と形状の変化が明らかになった.
- 構造の違いは,Gタンパク質とアストリン結合の決定因子を強調する.
結論:
- これらの構造的な発見は サイケデリックがHTR2Aを活性化させる方法について 分子的な洞察を与えてくれます
- これらの相互作用を理解することで 神経精神疾患に対する新しい選択的治療法の設計を導くことができます.
- この研究は,HTR2Aを標的とした治療薬の発見を加速します.
関連する概念動画
G-protein Coupled Receptors
130.0K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
130.0K
CNS Stimulants: Psychedelic Agents
497
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
497
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
740
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
740
G-Protein Gated Ion Channels
5.4K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
5.4K
G Protein-coupled Receptors
15.5K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
15.5K
Transducer Mechanism: G Protein–Coupled Receptors
3.5K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
3.5K


